|
|
| Inflammatory Bowel Disease Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor' s updated forecast will parallel its previous forecast up to 2012, several new product launches, regi ... |
| Johnson & Johnson: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ... |
| Lung Cancer Therapeutics |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. ... |
| Managing Sales Training to Accelerate Speed to Productivity |
|
| Table of Contents Published: 2009/07 Published by: Best Practices, LLC |
| Though effective sales training is a valuable investment, it is being cut back out of economic necessity. Given this reality and the fluctuation of company needs and competitive pressures, training roles and responsibilities, resources, contents and evalu ... |
| Medical Affairs Resources, Structures and Trends |
|
| Table of Contents Published: 2009/07 Published by: Best Practices, LLC |
| This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top ... |
| Medical Tourism Market Report: 2009 Edition |
|
| Table of Contents Published: 2009/07 Published by: Koncept Analytics |
| This report gives an overview of the medical tourism industry with focus on Asia. It discusses the major medical tourist destinations like Singapore, Thailand, Malaysia, India, Philippines, Taiwan and South Korea and their respective competitive advantage ... |
| Medicated Skin Care in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Medicated Skin Care in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Nanomedicine |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of 2006 through 201 ... |
| Novartis AG: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Novartis in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo ... |
| NRT Smoking Cessation Aids in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s NRT Smoking Cessation Aids in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Obesity Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, re ... |
| Osteoporosis Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong per ... |
| OTC Healthcare - United Arab Emirates |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s OTC Healthcare Products in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| OTC Healthcare in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| According to official data from the European Commission (based on research of the pharmaceuticals and OTC healthcare markets), the Slovak OTC healthcare market is traditional rather than innovative. ... |
| Personalized Medicine: Technologies and the Global Market |
|
| Table of Contents Published: 2009/07 Published by: BCC Research |
| Personalized diagnosis and treatment - or personalized medicine - is the most recent trend in the multibillion - dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order t ... |
| Pfizer Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Pfizer: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/07 Published by: Espicom Business Intelligence |
| Headquartered in New York, Pfizer has been the world' s largest research-based pharmaceutical company since it stole Merck & Co' s crown in 1998. The subsequent acquisition of Warner-Lambert (and with it Agouron) in June 2000 and the merger with Pharmacia ... |
| Prescription Drugs |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class -Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, An ... |
| Psoriasis Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This forecast model shows sales of key products used for the treatment of psoriasis, across the seven major markets. Forecast data to 2018 is psoriasis-specific and can be seen in both value and volume units. ... |
| Russia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| Russia's overall macroeconomic situation has stabilised markedly since the end of Q109 ? most notably
as the ruble's managed devaluation earlier in the year did not turn into a rout for the currency, or consume
all of the country's stability fund. Still ... |
| Small Molecule Kinase Inhibitors |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. ... |
| Spain Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| Spainfs pharmaceutical market, valued at EUR15.3bn in 2008, is expected to be cushioned from the
impact of the global financial crisis in the short term, with BMI forecasting nominal drug market
expenditure growth of 6% in euros between 2008 and 2009. ... |
|
|